Real-world efficacy of oral azvudine in hospitalized patients with COVID-19: A multicenter retrospective cohort study

DOI record: { "DOI": "10.1016/j.jiph.2025.102987", "ISSN": [ "1876-0341" ], "URL": "http://dx.doi.org/10.1016/j.jiph.2025.102987", "alternative-id": [ "S1876034125003363" ], "article-number": "102987", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Real-world efficacy of oral azvudine in hospitalized patients with COVID-19: A multicenter retrospective cohort study" }, { "label": "Journal Title", "name": "journaltitle", "value": "Journal of Infection and Public Health" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.jiph.2025.102987" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences." } ], "author": [ { "affiliation": [], "family": "Han", "given": "Rui", "sequence": "first" }, { "affiliation": [], "family": "Guan", "given": "Youhong", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Pulin", "sequence": "additional" }, { "affiliation": [], "family": "Tang", "given": "Min", "sequence": "additional" }, { "affiliation": [], "family": "Fei", "given": "Guanghe", "sequence": "additional" }, { "affiliation": [], "family": "Zeng", "given": "Daxiong", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Ran", "sequence": "additional" } ], "container-title": "Journal of Infection and Public Health", "container-title-short": "Journal of Infection and Public Health", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.com", "clinicalkey.com.au", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.jp", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 10, 9 ] ], "date-time": "2025-10-09T07:53:41Z", "timestamp": 1759996421000 }, "deposited": { "date-parts": [ [ 2025, 10, 12 ] ], "date-time": "2025-10-12T17:57:42Z", "timestamp": 1760291862000 }, "indexed": { "date-parts": [ [ 2025, 10, 12 ] ], "date-time": "2025-10-12T18:10:39Z", "timestamp": 1760292639781, "version": "build-2065373602" }, "is-referenced-by-count": 0, "issue": "12", "issued": { "date-parts": [ [ 2025, 12 ] ] }, "journal-issue": { "issue": "12", "published-print": { "date-parts": [ [ 2025, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 12, 1 ] ], "date-time": "2025-12-01T00:00:00Z", "timestamp": 1764547200000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 12, 1 ] ], "date-time": "2025-12-01T00:00:00Z", "timestamp": 1764547200000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 10, 6 ] ], "date-time": "2025-10-06T00:00:00Z", "timestamp": 1759708800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S1876034125003363?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S1876034125003363?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "102987", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 12 ] ] }, "published-print": { "date-parts": [ [ 2025, 12 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1002/jmv.25681", "article-title": "Emerging coronaviruses: genome structure, replication, and pathogenesis", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "418", "issue": "4", "journal-title": "J Med Virol", "key": "10.1016/j.jiph.2025.102987_bib1", "volume": "92", "year": "2020" }, { "DOI": "10.1056/NEJMoa2002032", "article-title": "Clinical characteristics of coronavirus disease 2019 in China", "author": "Guan", "doi-asserted-by": "crossref", "first-page": "1708", "issue": "18", "journal-title": "N Engl J Med", "key": "10.1016/j.jiph.2025.102987_bib2", "volume": "382", "year": "2020" }, { "DOI": "10.1038/s41422-022-00618-w", "article-title": "SARS-CoV-2 omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination", "author": "Li", "doi-asserted-by": "crossref", "first-page": "322", "issue": "3", "journal-title": "Cell Res", "key": "10.1016/j.jiph.2025.102987_bib3", "volume": "32", "year": "2022" }, { "DOI": "10.1038/s41392-022-00997-x", "article-title": "SARS-CoV-2 omicron variant: recent progress and future perspectives", "author": "Fan", "doi-asserted-by": "crossref", "first-page": "141", "issue": "1", "journal-title": "Signal Transduct Target Ther", "key": "10.1016/j.jiph.2025.102987_bib4", "volume": "7", "year": "2022" }, { "DOI": "10.1038/s41579-020-00459-7", "article-title": "Characteristics of SARS-CoV-2 and COVID-19", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "141", "issue": "3", "journal-title": "Nat Rev Microbiol", "key": "10.1016/j.jiph.2025.102987_bib5", "volume": "19", "year": "2021" }, { "DOI": "10.1038/s41422-022-00619-9", "article-title": "Reduced interferon antagonism but similar drug sensitivity in omicron variant compared to delta variant of SARS-CoV-2 isolates", "author": "Bojkova", "doi-asserted-by": "crossref", "first-page": "319", "issue": "3", "journal-title": "Cell Res", "key": "10.1016/j.jiph.2025.102987_bib6", "volume": "32", "year": "2022" }, { "DOI": "10.1056/NEJMc2119407", "article-title": "Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant", "author": "Takashita", "doi-asserted-by": "crossref", "first-page": "995", "issue": "10", "journal-title": "N Engl J Med", "key": "10.1016/j.jiph.2025.102987_bib7", "volume": "386", "year": "2022" }, { "DOI": "10.1016/j.ejmech.2023.115503", "article-title": "Bench-to-bedside: innovation of small molecule anti-SARS-CoV-2 drugs in China", "author": "Yang", "doi-asserted-by": "crossref", "journal-title": "Eur J Med Chem", "key": "10.1016/j.jiph.2025.102987_bib8", "volume": "257", "year": "2023" }, { "article-title": "The first Chinese oral anti-COVID-19 drug azvudine launched", "author": "Yu", "issue": "6", "journal-title": "Innov (Camb)", "key": "10.1016/j.jiph.2025.102987_bib9", "volume": "3", "year": "2022" }, { "DOI": "10.3390/healthcare13182319", "article-title": "Policy-Driven digital health interventions for health promotion and disease prevention: a systematic review of clinical and environmental outcomes", "author": "Faizan", "doi-asserted-by": "crossref", "first-page": "2319", "issue": "18", "journal-title": "Healthcare", "key": "10.1016/j.jiph.2025.102987_bib10", "volume": "13", "year": "2025" }, { "article-title": "A randomized, Open-Label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study", "author": "Ren", "issue": "19", "journal-title": "Adv Sci (Weinh)", "key": "10.1016/j.jiph.2025.102987_bib11", "volume": "7", "year": "2020" }, { "DOI": "10.1002/jmv.28947", "article-title": "Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: results of a real-world study", "author": "Yang", "doi-asserted-by": "crossref", "issue": "7", "journal-title": "J Med Virol", "key": "10.1016/j.jiph.2025.102987_bib12", "volume": "95", "year": "2023" }, { "DOI": "10.1016/j.eclinm.2023.101981", "article-title": "Oral azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study", "author": "Sun", "doi-asserted-by": "crossref", "journal-title": "EClinicalMedicine", "key": "10.1016/j.jiph.2025.102987_bib13", "volume": "59", "year": "2023" }, { "DOI": "10.1016/S0140-6736(23)00129-0", "article-title": "Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis", "author": "Pan", "doi-asserted-by": "crossref", "first-page": "664", "issue": "10377", "journal-title": "Lancet", "key": "10.1016/j.jiph.2025.102987_bib14", "volume": "401", "year": "2023" }, { "key": "10.1016/j.jiph.2025.102987_bib15", "unstructured": "General Office of the National Health Commission. Diagnosis and treatment protocol for COVID-19 in China (trial version 10). 2023 [cited 2023]Available from: 〈https://www.gov.cn/zhengce/zhengceku/2023-01/06/content_5735343.htm〉." }, { "DOI": "10.1001/jamainternmed.2020.6252", "article-title": "Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19", "author": "Gupta", "doi-asserted-by": "crossref", "first-page": "41", "issue": "1", "journal-title": "JAMA Intern Med", "key": "10.1016/j.jiph.2025.102987_bib16", "volume": "181", "year": "2021" }, { "key": "10.1016/j.jiph.2025.102987_bib17", "unstructured": "Organization WH. COVID-19 Therapeutic Trial Synopsis. 2020 2020.2.18 [cited 2022 2022.02.18]Available from: 〈https://www.who.int/publications/i/item/covid-19-therapeutic-trial-synopsis〉." }, { "key": "10.1016/j.jiph.2025.102987_bib18", "unstructured": "Propensity score matching in SPSS. 2012 [cited 2012]. Available from: 〈https://arxiv.org/abs/1201.6385〉." }, { "DOI": "10.1136/bmj.317.7172.1572", "article-title": "Survival probabilities (the Kaplan-Meier method)", "author": "Bland", "doi-asserted-by": "crossref", "first-page": "1572", "issue": "7172", "journal-title": "Bmj", "key": "10.1016/j.jiph.2025.102987_bib19", "volume": "317", "year": "1998" }, { "DOI": "10.1002/jmv.28756", "article-title": "Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: a retrospective cohort study", "author": "Deng", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "J Med Virol", "key": "10.1016/j.jiph.2025.102987_bib20", "volume": "95", "year": "2023" }, { "DOI": "10.1021/acs.jmedchem.0c00940", "article-title": "Mechanistic insight into antiretroviral potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting effect on HIV-1 prevention", "author": "Sun", "doi-asserted-by": "crossref", "first-page": "8554", "issue": "15", "journal-title": "J Med Chem", "key": "10.1016/j.jiph.2025.102987_bib21", "volume": "63", "year": "2020" }, { "DOI": "10.1038/s41392-021-00835-6", "article-title": "Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "414", "issue": "1", "journal-title": "Signal Transduct Target Ther", "key": "10.1016/j.jiph.2025.102987_bib22", "volume": "6", "year": "2021" }, { "DOI": "10.1021/acs.accounts.1c00697", "article-title": "4'-Modified nucleosides for antiviral drug discovery: achievements and perspectives", "author": "Chang", "doi-asserted-by": "crossref", "first-page": "565", "issue": "4", "journal-title": "Acc Chem Res", "key": "10.1016/j.jiph.2025.102987_bib23", "volume": "55", "year": "2022" }, { "DOI": "10.1016/j.jinf.2023.05.012", "article-title": "Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities", "author": "Dian", "doi-asserted-by": "crossref", "first-page": "e24", "issue": "2", "journal-title": "J Infect", "key": "10.1016/j.jiph.2025.102987_bib24", "volume": "87", "year": "2023" }, { "DOI": "10.1055/a-1300-2550", "article-title": "The role of glucocorticoids in the management of COVID-19", "author": "Alexaki", "doi-asserted-by": "crossref", "first-page": "9", "issue": "1", "journal-title": "Horm Metab Res", "key": "10.1016/j.jiph.2025.102987_bib25", "volume": "53", "year": "2021" }, { "DOI": "10.1371/journal.pone.0252057", "article-title": "Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia", "author": "Pinzón", "doi-asserted-by": "crossref", "issue": "5", "journal-title": "PLoS One", "key": "10.1016/j.jiph.2025.102987_bib26", "volume": "16", "year": "2021" }, { "DOI": "10.1093/cid/ciaa829", "article-title": "High-dose but not Low-dose corticosteroids potentially delay viral shedding of patients with COVID-19", "author": "Li", "doi-asserted-by": "crossref", "first-page": "1297", "issue": "7", "journal-title": "Clin Infect Dis", "key": "10.1016/j.jiph.2025.102987_bib27", "volume": "72", "year": "2021" }, { "article-title": "Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients", "author": "de Souza", "journal-title": "Front Med (Lausanne)", "key": "10.1016/j.jiph.2025.102987_bib28", "volume": "10", "year": "2023" }, { "DOI": "10.1016/j.heliyon.2023.e20153", "article-title": "Efficacy and safety of azvudine in patients with COVID-19: a systematic review and meta-analysis", "author": "Chen", "doi-asserted-by": "crossref", "issue": "9", "journal-title": "Heliyon", "key": "10.1016/j.jiph.2025.102987_bib29", "volume": "9", "year": "2023" }, { "article-title": "Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase", "author": "Wang", "journal-title": "Front Immunol", "key": "10.1016/j.jiph.2025.102987_bib30", "volume": "13", "year": "2022" }, { "DOI": "10.1038/s41392-022-01249-8", "article-title": "Small molecules in the treatment of COVID-19", "author": "Lei", "doi-asserted-by": "crossref", "first-page": "387", "issue": "1", "journal-title": "Signal Transduct Target Ther", "key": "10.1016/j.jiph.2025.102987_bib31", "volume": "7", "year": "2022" }, { "DOI": "10.1016/S1473-3099(22)00119-0", "article-title": "Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach", "author": "Dal-Ré", "doi-asserted-by": "crossref", "first-page": "e231", "issue": "8", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.jiph.2025.102987_bib32", "volume": "22", "year": "2022" }, { "DOI": "10.1038/s41598-023-37979-0", "article-title": "Using real-world evidence data and digital monitoring to analyze the hepatotoxic profiles of biologics across more than two million patients", "author": "Banerjee", "doi-asserted-by": "crossref", "issue": "1", "journal-title": "Sci Rep", "key": "10.1016/j.jiph.2025.102987_bib33", "volume": "13", "year": "2023" }, { "DOI": "10.1002/jmv.28926", "article-title": "Evaluate clinical effectiveness of azvudine with data rather than speculation", "author": "Li", "doi-asserted-by": "crossref", "issue": "7", "journal-title": "J Med Virol", "key": "10.1016/j.jiph.2025.102987_bib34", "volume": "95", "year": "2023" }, { "DOI": "10.3389/fphar.2023.1053814", "article-title": "How to use COVID-19 antiviral drugs in patients with chronic kidney disease", "author": "Kale", "doi-asserted-by": "crossref", "journal-title": "Front Pharm", "key": "10.1016/j.jiph.2025.102987_bib35", "volume": "14", "year": "2023" }, { "article-title": "All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis", "author": "Chen", "first-page": "103", "issue": "2", "journal-title": "Cardiol", "key": "10.1016/j.jiph.2025.102987_bib36", "volume": "8", "year": "2023" }, { "DOI": "10.1002/jmv.29007", "article-title": "Azvudine therapy of common COVID-19 in hemodialysis patients", "author": "Shang", "doi-asserted-by": "crossref", "issue": "8", "journal-title": "J Med Virol", "key": "10.1016/j.jiph.2025.102987_bib37", "volume": "95", "year": "2023" }, { "DOI": "10.1056/NEJMoa2110362", "article-title": "Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings", "author": "Thompson", "doi-asserted-by": "crossref", "first-page": "1355", "issue": "15", "journal-title": "N Engl J Med", "key": "10.1016/j.jiph.2025.102987_bib38", "volume": "385", "year": "2021" }, { "DOI": "10.1016/S0140-6736(21)00947-8", "article-title": "Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data", "author": "Haas", "doi-asserted-by": "crossref", "first-page": "1819", "issue": "10287", "journal-title": "Lancet (Lond Engl)", "key": "10.1016/j.jiph.2025.102987_bib39", "volume": "397", "year": "2021" }, { "DOI": "10.1016/S1473-3099(22)00732-0", "article-title": "Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study", "author": "Tsang", "doi-asserted-by": "crossref", "first-page": "421", "issue": "4", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.jiph.2025.102987_bib40", "volume": "23", "year": "2023" }, { "DOI": "10.1016/j.ejps.2017.05.009", "article-title": "Intestinal absorption mechanisms of 2′-deoxy-2′-β-fluoro-4′-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "150", "journal-title": "Eur J Pharm Sci", "key": "10.1016/j.jiph.2025.102987_bib41", "volume": "105", "year": "2017" }, { "article-title": "Effects of the antiretroviral drug 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions", "author": "Liu", "first-page": "503", "issue": "9", "journal-title": "Pharmazie", "key": "10.1016/j.jiph.2025.102987_bib42", "volume": "73", "year": "2018" }, { "DOI": "10.1080/08989621.2023.2269083", "article-title": "Spin in randomized controlled trials of pharmacology in COVID-19: a systematic review", "author": "Oh", "doi-asserted-by": "crossref", "first-page": "214", "issue": "3", "journal-title": "Acc Res", "key": "10.1016/j.jiph.2025.102987_bib43", "volume": "32", "year": "2025" } ], "reference-count": 43, "references-count": 43, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1876034125003363" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Real-world efficacy of oral azvudine in hospitalized patients with COVID-19: A multicenter retrospective cohort study", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "18" }